Cite
HARVARD Citation
Lucarini, L. et al. (2017). HYDAMTIQ, a selective PARP‐1 inhibitor, improves bleomycin‐induced lung fibrosis by dampening the TGF‐β/SMAD signalling pathway. Journal of cellular and molecular medicine. 21 (2), pp. 324-335. [Online].